Thu, Jul 18, 2024
The US Food and Drug Administration (USFDA) conducted inspection at the injectables manufacturing facility between April 15 and April 23, 2024, Zydus Lifesciences said in a regulatory filing.
More >
Wed, Jul 17, 2024
The company has entered into a non-exclusive patent licensing agreement with Takeda Pharmaceutical Company to market the novel Potassium Competitive Acid Blocker (P-CAB) Vonoprazan in India, the drug firm said in a statement.
Fri, Jul 05, 2024
Stock Market: The domestic stock market had a weak start on Friday (July 5). There is selling pressure in banking shares. Amid the market decline, brokerage firm Motilal Oswal has made pharma sector giant Zydus Lifesciences a technical pick. Brokerage has advised buying in Zydus lifescience for 2-3 days.
Thu, Mar 28, 2024
Zydus Lifesciences share price, Zydus Lifesciences USFDA observations: Zydus Lifesciences shares opened at Rs 993 on the NSE, down over 0.5 per cent from the previous close of Rs 999.7. At 9:39 am, the counter traded at Rs 1,006.3, up 0.66 per cent on the NSE.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
